litlas
Log inCreate account

Jianjun Zhang

Active 1989–2026

848
Papers
56,609
Citations
117
h-index
608
i10-index

Citations

Citations per year for Jianjun Zhang1989: 1 citations1990: 6 citations1991: 10 citations1992: 13 citations1993: 12 citations1994: 9 citations1995: 6 citations1996: 8 citations1997: 14 citations1998: 24 citations1999: 25 citations2000: 27 citations2001: 19 citations2002: 23 citations2003: 24 citations2004: 27 citations2005: 36 citations2006: 42 citations2007: 55 citations2008: 49 citations2009: 53 citations2010: 57 citations2011: 66 citations2012: 82 citations2013: 104 citations2014: 151 citations2015: 190 citations2016: 277 citations2017: 376 citations2018: 478 citations2019: 1,421 citations2020: 1,958 citations2021: 2,382 citations2022: 2,270 citations2023: 2,110 citations2024: 3,297 citations2025: 2,279 citations2026: 202 citations

Citation sources

Countries

World map of the countries and regions citing this authorChina: 7,368 citing papers, 31.1% of this breakdownUnited States: 4,182 citing papers, 17.7% of this breakdownUnited Kingdom: 1,020 citing papers, 4.3% of this breakdownItaly: 817 citing papers, 3.4% of this breakdownGermany: 778 citing papers, 3.3% of this breakdownIndia: 605 citing papers, 2.5% of this breakdownFrance: 594 citing papers, 2.5% of this breakdownJapan: 583 citing papers, 2.5% of this breakdownAustralia: 582 citing papers, 2.5% of this breakdownCanada: 582 citing papers, 2.5% of this breakdownSpain: 484 citing papers, 2% of this breakdownSouth Korea: 471 citing papers, 2% of this breakdown
0%31.1%Other 23.7%

Institutions

Fields

  • Medicine39.2%
  • Biochemistry, Genetics and Molecular Biology27.3%
  • Engineering8.8%
  • Computer Science6.7%
  • Immunology and Microbiology3.2%
  • Agricultural and Biological Sciences2.3%
  • Other12.5%

Topics

  • Cancer Immunotherapy and Biomarkers4.2%
  • Lung Cancer Treatments and Mutations3.7%
  • Cancer Genomics and Diagnostics2.7%
  • MicroRNA in disease regulation2%
  • Lung Cancer Research Studies2%
  • Cancer-related molecular mechanisms research1.8%
  • Other83.6%

Coauthors

All papers

Open in search
  1. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

    Authors: Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach - Cancer Discovery 2018 cited by 1,604

  2. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma

    Authors: Yan Zhou, Yang Dong, Qingcheng Yang, Xiaobin Lv, Wentao Huang, Zhenhua Zhou, Yaling Wang, Zhichang Zhang, Ting Yuan, Xiaomin Ding, Lina Tang, Jianjun Zhang, Junyi Yin, Yujing Huang, Wenxi Yu, Yonggang Wang, Chenliang Zhou, Su Yang, Aina He, Yuanjue Sun, Zan Shen, Bin‐Zhi Qian, Wei Meng, Jia Fei, Yang Yao, Xinghua Pan, Peizhan Chen, Haiyan Hu - Nature Communications 2020 cited by 687

  3. Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

    Authors: Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao, Vassiliki A. Papadimitrakopoulou, Pan Tong, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez Canales, Jianjun Zhang, Uma Giri, Jayanthi Gudikote, María Angélica Cortez, Chao Yang, You-Hong Fan, Michael Peyton, Luc Girard, Kevin R. Coombes, Carlo Toniatti, Timothy P. Heffernan, Murim Choi, Garrett M. Frampton, Vincent A. Miller, John N. Weinstein, Roy S. Herbst, Kwok‐Kin Wong, Jianhua Zhang, Padmanee Sharma, Gordon B. Mills, Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach - Cancer Discovery 2015 cited by 916

  4. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    Authors: Biagio Ricciuti, Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong, Jianjun Zhang, Michael Tolstorukov, Yvonne Y. Li, Liam F. Spurr, Andrew D. Cherniack, Gonzalo Recondo, Giuseppe Lamberti, Xinan Wang, Deepti Venkatraman, Joao V. Alessi, Victor R. Vaz, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, S. Khosrowjerdi, Subba R. Digumarthy, Hyesun Park, Nuno Vaz, Mizuki Nishino, Lynette M. Sholl, David A. Barbie, Mehmet Altan, John V. Heymach, Ferdinandos Skoulidis, Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 cited by 367

  5. Structure-based classification predicts drug response in EGFR-mutant NSCLC

    Authors: Jacqulyne Robichaux, Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin, Heather Lin, Hibiki Udagawa, Ferdinandos Skoulidis, Hai T. Tran, Susan Varghese, Junqin He, Fahao Zhang, Monique B. Nilsson, Lemei Hu, Alissa Poteete, Waree Rinsurongkawong, Xiaoshan Zhang, Chenghui Ren, Xiaoke Liu, Lingzhi Hong, Jianjun Zhang, Lixia Diao, Russell W. Madison, Alexa B. Schrock, Jennifer Saam, Victoria M. Raymond, Bingliang Fang, Jing Wang, Min Jin Ha, Jason B. Cross, Jhanelle E. Gray, John V. Heymach - Nature 2021 cited by 452

  6. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    Authors: Daniel R. Gomez, Chad Tang, Jianjun Zhang, George R. Blumenschein, Mike Hernández, J. Jack Lee, Rong Ye, David A. Palma, Alexander V. Louie, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, James W. Welsh, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Anne S. Tsao, Boris Sepesi, Stephen G. Swisher, John V. Heymach - Journal of Clinical Oncology 2019 cited by 1,270

  7. TMSDNet: Transformer with multi-scale dense network for single and multi-view 3D reconstruction

    Authors: Xiaoqiang Zhu, Xinsheng Yao, Junjie Zhang, Junjie Zhang, Mengyao Zhu, Lihua You, Xiaosong Yang, Jianjun Zhang, Jianjun Zhang, He Zhao, Dan Zeng - Computer Animation and Virtual Worlds, Comput. Animat. Virtual Worlds 2023 cited by 103

  8. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

    Authors: Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy, Hope Feldman, William N. William, Yuanxin Xi, Sreyashi Basu, Jing Sun, Shalini S. Yadav, Frank Rojas Alvarez, Younghee Lee, Aditya K. Mishra, Lili Chen, Monika Pradhan, Haiping Guo, Ansam Sinjab, Nicolas Zhou, Marcelo V. Negrão, Xiuning Le, Carl M. Gay, Anne S. Tsao, Lauren A. Byers, Mehmet Altan, Bonnie S. Glisson, Frank V. Fossella, Yasir Y. Elamin, George Blumenschein, Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J. Mehran, David C. Rice, Garrett L. Walsh, Wayne L. Hofstetter, Ravi Rajaram, Mara B. Antonoff, Junya Fujimoto, Luisa M. Solis, Edwin R. Parra, Cara Haymaker, Ignacio I. Wistuba, Stephen G. Swisher, Ara A. Vaporciyan, Heather Lin, Jing Wang, Don L. Gibbons, J. Jack Lee, Nadim J. Ajami, Jennifer A. Wargo, James P. Allison, Padmanee Sharma, Humam Kadara, John V. Heymach, Boris Sepesi - Nature Medicine 2023 cited by 206

  9. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

    Authors: Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou, Lukas Delasos, J. Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V. Aredo, Michael J. Dennis, Turja Chakrabarti, Susan C. Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W. Riess, So Yeon Kim, Sarah B. Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong, Richard Lee, Biagio Ricciuti, Joao V. Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 cited by 181

  10. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

    Authors: Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y. Elamin, Xiuning Le, Michael E. Goldberg, Karthikeyan Murugesan, Chang‐Jiun Wu, Jianhua Zhang, Jianhua Zhang, David S Barreto, Jacqulyne Robichaux, Alexandre Reuben, Tina Cascone, Carl M. Gay, K. G. Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Anne S. Tsao, Vassiliki A. Papadimitrakopoulou, Don L. Gibbons, Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian M. Alexander, Garrett M. Frampton, Lee A. Albacker, David S. Shames, Jianjun Zhang, Jianjun Zhang, John V. Heymach - Journal for ImmunoTherapy of Cancer 2021 cited by 292

  11. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

    Authors: C. Allison Stewart, Carl M. Gay, Yuanxin Xi, Santhosh Sivajothi, V. Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M. Hartsfield, Veerakumar Balasubramaniyan, Milind D. Chalishazar, César A. Moran, Neda Kalhor, John Stewart, Hai T. Tran, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, John de Groot, Bonnie S. Glisson, Trudy G. Oliver, John V. Heymach, Ignacio I. Wistuba, Paul Robson, Jing Wang, Lauren A. Byers - Nature Cancer 2020 cited by 372

  12. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

    Authors: Joe Y. Chang, Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay, Jianjun Zhang, Stephen G. Chun, Yasir Y. Elamin, Frank V. Fossella, George R. Blumenschein, Tina Cascone, Xiuning Le, J.V. Pozadzides, Anne S. Tsao, Vivek Verma, James W. Welsh, Aileen B. Chen, Mehmet Altan, Reza J. Mehran, Ara A. Vaporciyan, Stephen G. Swisher, Peter Balter, Junya Fujimoto, Ignacio I. Wistuba, Lei Feng, J Jack Lee, John V. Heymach - The Lancet 2023 cited by 224

  13. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Authors: Daniel R. Gomez, George R. Blumenschein, J Jack Lee, Mike Hernández, Rong Ye, D. Ross Camidge, Robert C. Doebele, Ferdinandos Skoulidis, Laurie E. Gaspar, Don L. Gibbons, José A. Karam, Brian D. Kavanagh, Chad Tang, Ritsuko Komaki, Alexander V. Louie, David A. Palma, Anne S. Tsao, Boris Sepesi, William N. William, Jianjun Zhang, Qiuling Shi, Xin Shelley Wang, Stephen G. Swisher, John V. Heymach - The Lancet Oncology 2016 cited by 1,086

  14. Joint Optimization in Blockchain- and MEC-Enabled Space-Air-Ground Integrated Networks

    Authors: Jianbo Du, Jiaxuan Wang, Aijing Sun, Junsuo Qu, Jianjun Zhang, Celimuge Wu, Dusit Niyato - IEEE Internet of Things Journal, IEEE Internet Things J. 2024 cited by 57

  15. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

    Authors: Xing Qin, Haiyan Guo, Xiaoning Wang, Xueqin Zhu, Ming Yan, Xu Wang, Qin Xu, Jianbo Shi, Eryi Lu, Wantao Chen, Jianjun Zhang - Genome biology 2019 cited by 462

  16. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36

    Authors: Zhiyong Qi, Liang Hu, Jianjun Zhang, Wenlong Yang, Xin Liu, Daile Jia, Zhifeng Yao, Lin Chang, Guanxing Pan, Haoxuan Zhong, Xinping Luo, Kang Yao, Aijun Sun, Juying Qian, Zhongren Ding, Junbo Ge - Circulation 2020 cited by 274

  17. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

    Authors: Jianjun Zhang, Junya Fujimoto, Jianhua Zhang, David C. Wedge, Xingzhi Song, Jiexin Zhang, Sahil Seth, Chi‐Wan Chow, Yu Cao, Curtis Gumbs, Kathryn A. Gold, Neda Kalhor, Latasha Little, Harshad S. Mahadeshwar, César A. Moran, Alexei Protopopov, Huandong Sun, Jiabin Tang, Xifeng Wu, Yuanqing Ye, William N. William, J. Jack Lee, John V. Heymach, Waun Ki Hong, Stephen G. Swisher, Ignacio I. Wistuba, P. Andrew Futreal - Science 2014 cited by 1,014

  18. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

    Authors: Simon Heeke, Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang, Ximing Tang, Maria Gabriela Raso, Pedro Rocha, Siqi Lai, Edurne Arriola, Paul Hofman, Véronique Hofman, Prasad Kopparapu, Christine M. Lovly, Kyle Concannon, Luana Guimarães de Sousa, Whitney E. Lewis, Kimie Kondo, Xin Hu, Azusa Tanimoto, Natalie I. Vokes, Monique B. Nilsson, Allison Stewart, M. Jansen, Ildikó Horváth, Mina Gaga, Vasileios Panagoulias, Yael Raviv, Danny Frumkin, Adam Wasserstrom, Aharona Shuali, Catherine A. Schnabel, Yuanxin Xi, Lixia Diao, Qi Wang, Jianjun Zhang, Peter Van Loo, Jing Wang, Ignacio I. Wistuba, Lauren A. Byers, John V. Heymach - Cancer Cell 2024 cited by 112

  19. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

    Authors: Grant M. Fischer, Ali Jalali, David A. Kircher, Won‐Chul Lee, Jennifer L. McQuade, Lauren E. Haydu, Aron Y. Joon, Alexandre Reuben, Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Chendong Yang, Anuj Srivastava, Chandrashekar R. Ambati, Arun Sreekumar, Courtney W. Hudgens, Barbara Knighton, Wanleng Deng, Sherise D. Ferguson, Hussein A. Tawbi, Isabella C. Glitza, Jeffrey E. Gershenwald, Y.N. Vashisht Gopal, Patrick Hwu, Jason T. Huse, Jennifer A. Wargo, P. Andrew Futreal, Nagireddy Putluri, Alexander J. Lazar, Ralph J. DeBerardinis, Joseph R. Marszalek, Jianjun Zhang, Sheri L. Holmen, Michael T. Tetzlaff, Michael A. Davies - Cancer Discovery 2019 cited by 347

  20. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

    Authors: Yanhua Tian, Qingqing Li, Zhenlin Yang, Shu Zhang, Jiachen Xu, Zhijie Wang, Hua Bai, Jianchun Duan, Bo Zheng, Wen Li, Yueli Cui, Xin Wang, Rui Wan, Kailun Fei, Jia Zhong, Shugeng Gao, Jié He, Carl M. Gay, Jianjun Zhang, Jie Wang, Fuchou Tang - Signal Transduction and Targeted Therapy 2022 cited by 148

  21. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review

    Authors: Qasem Al-Tashi, Maliazurina B. Saad, Amgad Muneer, Rizwan Qureshi, Seyedali Mirjalili, Ajay Sheshadri, Xiuning Le, Natalie I. Vokes, Jianjun Zhang, Jia Wu - International Journal of Molecular Sciences 2023 cited by 139

  22. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

    Authors: Maliazurina B. Saad, Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi, Kang Qin, Sheeba J. Sujit, Xuetao Lu, Elliana Young, Qasem Al-Tashi, Rizwan Qureshi, Carol C. Wu, Brett W. Carter, Steven H. Lin, Percy P. Lee, Saumil Gandhi, Joe Y. Chang, Ruijiang Li, Michael F. Gensheimer, Heather A. Wakelee, Joel W. Neal, Hyun‐Sung Lee, Chao Cheng, Vamsidhar Velcheti, Yanyan Lou, Milena Petranović, Waree Rinsurongkawong, Xiuning Le, Vadeerat Rinsurongkawong, Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrão, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, Mara B. Antonoff, Boris Sepesi, Jeff Lewis, Ignacio I. Wistuba, John D. Hazle, Caroline Chung, David A. Jaffray, Don L. Gibbons, Ara A. Vaporciyan, J Jack Lee, John V. Heymach, Jianjun Zhang, Jia Wu - The Lancet Digital Health 2023 cited by 109

  23. Large deformation and energy absorption of additively manufactured auxetic materials and structures: A review

    Authors: Jianjun Zhang, Guoxing Lu, Zhong You - Composites Part B Engineering 2020 cited by 655

  24. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma

    Authors: Xiao Meng, Jianjun Zhang, Wanjun Chen, Wantao Chen, Wantao Chen, Wantao Chen - Journal of Experimental & Clinical Cancer Research 2018 cited by 265